MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-04-0010174
Biotavia Labs Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹83.55 Cr
▼ 56% YoY
Net loss · FY 2025
₹1.77 Cr
Net margin -2.1%
EBITDA · FY 2025
₹70.24 Lakh
EBITDA margin 0.8%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.56 Cr
Issued & subscribed
Open charges
₹24.14 Cr
Satisfied ₹25.65 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
4
Provident fund records
About Biotavia Labs Private Limited
Data last updated:
Biotavia Labs Private Limited is a private limited company based in Delhi, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 29 September 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85121DL2006PTC154528. Its GSTIN is 07AAFCA9442A1ZZ (Delhi). The company holds 4 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.56 Cr. It was formerly known as Actavia Labs Private Limited. It is led by directors Vipul Goel and Sameer Goel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 972 Aggarwal Millenium Tower II Netaji Subhash Place Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹83.55 Cr, a decline of 56% compared to the previous year. For the same year it recorded a net loss of ₹1.77 Cr (net margin -2.1%) and EBITDA of ₹70.24 Lakh (EBITDA margin 0.8%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 15% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Biotavia. As per MCA filings, the company has open charges of ₹24.14 Cr and satisfied charges of ₹25.65 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company. The company has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹35 Lakh; the latest was in September 2021. Its 10 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Prachi Pharmaceuticals Private Limited with revenue of ₹85.43 Cr.
Biotavia Labs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-04-0010174). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biotavia.com.
Company details
CIN U85121DL2006PTC154528
Registration Number 154528
Incorporation Date 29 September 2006
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-04-0010174
Key People
Vipul Goel Director Sameer Goel Director Recognitions & Rankings of Biotavia Labs
Contact details
Biotavia Labs Private Limited's registered office is in Delhi, Delhi. Its website is biotavia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address972 Aggarwal Millenium Tower II Netaji Subhash Place Pitampura, Delhi, India – 110034
- IndustryPharma, API Manufacturers
To see the full contact details of Biotavia Labs Private Limited, buy the company report.
Comprehensive company report
Biotavia Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Biotavia Labs operates one associated brand: Biotavia. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and trading of high-quality Active Pharmaceutical Ingredients and Intermediates in India. | biotavia.com |
Business activity
The main business activity of Biotavia Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Biotavia Labs Private Limited, buy the company report.
Financials of Biotavia Labs Private Limited
FY 2024 filings availableBiotavia Labs Private Limited reported revenue of ₹83.55 Cr (down 56% YoY) for FY 2025.
Revenue · FY 2025
₹83.55 Cr ▼ 56%
Net loss · FY 2025
₹1.77 Cr margin -2.1%
EBITDA · FY 2025
₹70.24 Lakh margin 0.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 56%
3 years · compounded
▼ 17%
5 years · compounded
▼ 15%
EBITDA CAGR growth
1 year
▼ 79%
3 years · compounded
▼ 46%
5 years · compounded
▼ 29%
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 56% fall in the latest year. EBITDA fell 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹70.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.77 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | -2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biotavia Labs Private Limited, buy the company report.
Board of directors of Biotavia Labs Private Limited
Biotavia Labs has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vipul Goel Also directs: Biotavia Pharm Private Limited, Zeneses Biosciences Private Limited, Actaviaa Biotech Private Limited and 1 more | Director | 10 Apr 2009 | 17 Years 6 Months | Current |
| Sameer Goel Also directs: Biotavia Pharm Private Limited, Zeneses Biosciences Private Limited, Actaviaa Biotech Private Limited and 3 more | Director | 15 Jun 2021 | 5 Years 4 Months | Current |
Peer comparison
Biotavia Labs Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prachi Pharmaceuticals Private Limited | ₹85.43 Cr (FY 2024) | -3.0% | Mumbai, Maharashtra, India | |||
| Hema Pharmaceuticals Pvt Ltd | ₹85.23 Cr (FY 2025) | 17.0% | Ankleshwar, Gujarat, India | |||
| Brundavan Laboratories Private Limited | ₹84.25 Cr (FY 2025) | 32.0% | Hyderabad, Telangana, India | |||
| Inchem Laboratories Private Limited | ₹84.08 Cr (FY 2025) | 12.0% | Hyderabad, Telangana, India | |||
| Adroit Pharmachem Private Limited | ₹83.57 Cr (FY 2025) | 34.0% | Vadodara, Gujarat, India | |||
| Biotavia Labs Private Limitedthis company | ₹83.55 Cr (FY 2025) | -₹1.77 Cr | -2.1% | -56.0% | 4 | Delhi, India |
| SNJ Labs Private Limited | ₹83.01 Cr (FY 2025) | 28.0% | Rajkot, Gujarat, India | |||
| Adeep Life Sciences Private Limited | ₹82.67 Cr (FY 2024) | 87.0% | Hyderabad, Telangana, India | |||
| Abhilash Chemicals and Pharmaceuticals Private Limited | ₹82.45 Cr (FY 2025) | -16.0% | Madurai, Tamil Nadu, India | |||
| Bioxera Pharma Private Limited | ₹79.2 Cr (FY 2025) | 24.0% | Mumbai, Maharashtra, India | |||
| Clarion Organics Limited | ₹78.17 Cr (FY 2024) | 14.0% | Bhandara, Maharashtra, India |
To see the full peer comparison of Biotavia Labs Private Limited, buy the company report.
Auditor
Biotavia Labs Private Limited is audited by Ravi Varshney & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ravi Varshney & Associates | FY 2024 | 026213N |
Shareholding
The shareholding of Biotavia Labs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Biotavia Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹24.14 Cr
Satisfied charges
₹25.65 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Apr 2023 | 100708803 | Hdfc Bank Limited | ₹24.14 Cr | Satisfied | |
| 21 Dec 2011 | 10324118 | Hdfc Bank Limited | ₹36,000 | Satisfied | |
| 11 Aug 2007 | 10065191 | Icici Bank Limited | ₹1.5 Cr | Satisfied |
To see the full charge records of Biotavia Labs Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Biotavia Labs Private Limited has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹35 Lakh; the latest was in September 2021.
Total deals
6
Secondary share transfers
5
Funding round
1
Disclosed funding
₹35 Lakh
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: Zeneses Biosciences Private Limited , Biotavia Pharm Limited. Seller: Sonvardaa Vyapaar Private Limited, Khushboo Complex Private Limited, Subhdrishti Complex Private Limited |
| Mar 2008 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Vaishali Infosystem India Private Limited . , Satwant Singh Sodhi Construction Private Limited, Walcon India Private Limited |
| Mar 2007 | Funding round | ₹35 Lakh | Investors: Satwant Singh Sodhi Construction Private Limited, Midas Touch Media Private Limited , Bhalotia Agro Industries Ltd. |
To see the full deal history of Biotavia Labs Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Biotavia Labs Private Limited has 3 court cases on record: 3 filed by Biotavia Labs. All cases are disposed.
Total cases
3
Filed by the company
3
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 0 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Criminal case | Filed by the company against M/S Nityam Pharma and 2 others | Disposed |
| District court, North West, Delhi | Criminal case | Filed by the company against M/S Nitya Pharma and 2 others | Disposed |
To see the full case history of Biotavia Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biotavia Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Biotavia Labs has 1 associated company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Biotavia Labs Private Limited has a workforce of 4 employees on its EPFO records as of Mar 31, 2025, across 1 active EPFO establishment.
Employee count
4
Active EPFO establishments
1
Employee growth
-20%
GST
Biotavia Labs has 4 GST registrations: 1 active and 3 cancelled or inactive.
Total GSTINs
4
Active
1
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCA9442A1ZZ | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Biotavia Labs Private Limited, buy the company report.
Recent activity
Biotavia Labs Private Limited has 6 board changes on record since 2009: 2 appointments and 4 cessations. The latest: Deepa Goel ceased to be Additional Director on 01 Mar 2022.
Charges
A charge registered on 12 Apr 2023 via Charge ID 100708803 with Hdfc Bank Limited was fully satisfied on 05 Jun 2025.
AGM
Biotavia Labs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Biotavia Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge registered on 21 Dec 2011 via Charge ID 10324118 with Hdfc Bank Limited was fully satisfied on 26 Apr 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 24.14 Cr with Charge ID 100708803 was registered on 12 Apr 2023.
Ceased
Deepa Goel ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited of Rs. 0.00 Cr registered on 21 Dec 2011 with Charge ID 10324118 was modified on 17 Feb 2022.
Ceased
Sameer Goel ceased to be Additional Director.
Appointed
Sameer Goel was appointed as Director.
Ceased
Sachin Goel ceased to be Director.
Ceased
Vipul Goel ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.00 Cr with Charge ID 10324118 was registered on 21 Dec 2011.
4 earlier events are in the company report.
Frequently asked questions
Biotavia Labs is an active private limited company based in Delhi, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 29 September 2006 (20+ years old) and is registered under CIN U85121DL2006PTC154528.
Biotavia Labs has 2 current directors:
- Vipul Goel - Director
- Sameer Goel - Director
The latest financial statements of Biotavia Labs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Biotavia Labs is 07AAFCA9442A1ZZ, registered in Delhi. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.
The CIN (Corporate Identification Number) of Biotavia Labs is U85121DL2006PTC154528. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biotavia Labs has 3 court cases on record: 3 filed by the company.
Biotavia Labs was incorporated on 29 September 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
Biotavia Labs has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹35 Lakh; the latest was in September 2021.
The peers of Biotavia Labs by revenue are Prachi Pharmaceuticals Private Limited, Hema Pharmaceuticals Pvt Ltd, Brundavan Laboratories Private Limited, Inchem Laboratories Private Limited, Adroit Pharmachem Private Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Deepa Goel ceased to be Additional Director on 01 Mar 2022. Sameer Goel ceased to be Additional Director on 30 Nov 2021. Sameer Goel was appointed as Director on 15 Jun 2021. Biotavia Labs has 6 board changes on record in total.
Yes, Biotavia Labs is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-04-0010174).